Results 231 to 240 of about 116,589 (255)

Advanced Glycation End Products in Neurodegenerative Diseases

Journal of Molecular Neuroscience
Advanced glycation end products (AGEs) have attracted interest as therapeutic targets for neurodegenerative diseases. AGEs facilitate the onset and progression of various neurogenerative disorders due to their ability to promote cross-linking and aggregation of proteins.
openaire   +2 more sources

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Hemodialysis Techniques and Advanced Glycation End Products

2000
TESSITORE N., LAPOLLA, ANNUNZIATA, ARICO' C. N., GAMMARO L., BERNICH P., FEDELE D.   +5 more
openaire   +4 more sources

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Advanced Glycation End-Products

2013
openaire   +1 more source

Artificial intelligence in cancer imaging: Clinical challenges and applications

Ca-A Cancer Journal for Clinicians, 2019
Wenya Linda Bi, Ahmed Hosny, Matthew B Schabath   +2 more
exaly  

Nutrition and physical activity guidelines for cancer survivors

Ca-A Cancer Journal for Clinicians, 2012
Cheryl L Rock, Wendy Demark-Wahnefried, Kerry S Courneya   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly